Revance Therapeutics Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 675

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 17

  • Investments
  • 3

Revance Therapeutics General Information

Description

Developer of botulinum toxin products intended to be used in aesthetic and therapeutic applications. The company specializes in healthcare with innovative aesthetic and therapeutic offerings, thereby helping physicians, patients, and consumers enhance their outcomes and experiences significantly.

Contact Information

Website
www.revance.com
Formerly Known As
Essentia Biosystems
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • 1222 Demonbreun Street
  • 20th Floor
  • Nashville, TN 37203
  • United States
+1 (510)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Personal Products
Parent Company
Vertical(s)
Former Stock Listing
RVNC
Corporate Office
  • 1222 Demonbreun Street
  • 20th Floor
  • Nashville, TN 37203
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Revance Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Revance Therapeutics‘s full profile, request access.

Request a free trial

Revance Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of botulinum toxin products intended to be used in aesthetic and therapeutic applications. The company special
Drug Discovery
Nashville, TN
675 As of 2025

Pasadena, CA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Revance Therapeutics Competitors (27)

One of Revance Therapeutics’s 27 competitors is Meditope Biosciences, a Formerly VC-backed company based in Pasadena, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Meditope Biosciences Formerly VC-backed Pasadena, CA
Genentech Formerly VC-backed South San Francisco, CA
PhoreMost Venture Capital-Backed Cambridge, United Kingdom
Agenus Formerly VC-backed Lexington, MA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 27 competitors. Get the full list »

Revance Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Revance Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Revance Therapeutics‘s full profile, request access.

Request a free trial

Revance Therapeutics Investments & Acquisitions (3)

Revance Therapeutics’s most recent deal was a Merger/Acquisition with HintMD for . The deal was made on 23-Jul-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
HintMD 23-Jul-2020 Merger/Acquisition Other Healthcare Services
Inner Resource 13-Feb-2019 Early Stage VC Business/Productivity Software
Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) 02-Jun-2016 Corporate Asset Purchase Buildings and Property
To view Revance Therapeutics’s complete investments and acquisitions history, request access »

Revance Therapeutics FAQs

  • When was Revance Therapeutics founded?

    Revance Therapeutics was founded in 1999.

  • Where is Revance Therapeutics headquartered?

    Revance Therapeutics is headquartered in Nashville, TN.

  • What is the size of Revance Therapeutics?

    Revance Therapeutics has 675 total employees.

  • What industry is Revance Therapeutics in?

    Revance Therapeutics’s primary industry is Drug Discovery.

  • Is Revance Therapeutics a private or public company?

    Revance Therapeutics is a Private company.

  • What is the current valuation of Revance Therapeutics?

    The current valuation of Revance Therapeutics is .

  • What is Revance Therapeutics’s current revenue?

    The current revenue for Revance Therapeutics is .

  • How much funding has Revance Therapeutics raised over time?

    Revance Therapeutics has raised $921M.

  • Who are Revance Therapeutics’s investors?

    Bio*One Capital, , Brown Brothers Harriman, CNF Investments, and Delphi Ventures (California) are 5 of 17 investors who have invested in Revance Therapeutics.

  • Who are Revance Therapeutics’s competitors?

    Meditope Biosciences, Genentech, PhoreMost, Agenus, and CytomX Therapeutics are some of the 27 competitors of Revance Therapeutics.

  • When was Revance Therapeutics acquired?

    Revance Therapeutics was acquired on 06-Feb-2025.

  • Who acquired Revance Therapeutics?

    Revance Therapeutics was acquired by Crown Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process